Oklo and NuScale Power Have Shed a Combined 85.3% This Year. Why Are Nuclear Stocks Falling?

Oklo shares are down ~44% YTD and NuScale Power shares are down ~41%, despite Bank of America framing a potential $10 trillion nuclear opportunity. The article attributes the underperformance to investors’ risk-off behavior toward small modular reactor (SMR) developers that are years from commercialization (cash flows not expected until well after approval/2030+ adoption). It also flags ongoing quarterly losses and likely continued dilution until meaningful customer commitments emerge (adoption not expected before ~2035–2040), contributing to near-term financial-position concerns.

Analysis

The market is re-rating these names as venture-stage duration bets, not as near-term beneficiaries of the nuclear buildout theme. That matters because when cash flows sit years out, valuation is driven less by TAM headlines and more by the next financing event, so even a small deterioration in risk appetite or a higher-for-longer rate backdrop can overwhelm the secular story.

The first-order losers are the common equities; the second-order losers are any future project partners that need these developers to become bankable, because delays push procurement to incumbents with real cash generation. By contrast, cash-flowing nuclear operators and large-scale power providers can absorb AI-driven load growth now, while investment banks like BAC only monetize once the projects move from narrative to a financed cap stack.

Over the next 1-3 months, the key catalyst is not demand rhetoric but milestones: regulatory approval, anchor-customer contracts, and whether a capital raise clears without punitive dilution. Over 6-18 months, the thesis reverses only if rates fall materially and at least one SMR developer proves it can secure non-dilutive funding or a credible commercial deployment path. The contrarian view is that the selloff may still be incomplete if the market is underestimating how many years of dilution are required before revenue becomes visible.

Key Decisions for Investors

• Short OKLO or SMR on any 1-2 day rally; 1-3 month thesis is financing fatigue and multiple compression, with the trade invalidated by a credible non-dilutive project-finance announcement or regulator approval.
• Pair long CEG against short SMR over the next 1-3 months: own cash-flowing nuclear exposure while fading pre-revenue optionality; expect better downside capture if real yields stay firm.
• If you want cleaner AI power exposure, rotate from SMR into NVDA: long NVDA / short SMR is a relative-value expression that monetizes AI demand now instead of waiting for 2030+ nuclear buildouts.
• For event-driven accounts, buy 3-6 month put spreads on OKLO after any policy/AI headline spike; use the premium sale to finance convex downside if no backlog or funding milestone follows.
• Set a watch item on 10-year yields and any disclosed project financing terms; a sharp drop in rates or an oversubscribed raise would falsify the short thesis quickly.